ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1458	National Cancer Institute	Html	en	Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Patient Version	Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.	cancer treatment 0.511187 cancer prevention trials 0.526349 prevention clinical trials 0.527895 protective factors 0.503231 new cancers 0.484789 nicotine withdrawal symptoms 0.507568 PDQ cancer information 0.671083 lung cancer 0.635933 Lung Health Study 0.490849 clinical trials 0.665449 cancer information summary 0.600276 health care professionals 0.488661 clinical trial 0.538396 breast cancer prevention 0.507807 PDQ summaries 0.484382 Childhood cancer survivors 0.595809 smoking reduction 0.509721 cancer risk factor 0.545024 NCI’s PDQ 0.484019 NCI PDQ cancer 0.553403 health problems 0.510567 cancer recurrence 0.485421 nicotine replacement products 0.747838 nicotine replacement product 0.508467	Cancer prevention 0.618116 cancer protective factor 0.526183 smokers 0.498248 Cancer Information Service 0.517443 smoking 0.827105 Prevention Editorial Board 0.530978 treatment clinical trials 0.488401 National Cancer Institute 0.611044 cancer death 0.488965 health care 0.546707 new treatment 0.493726 PDQ Cigarette Smoking 0.572693 Cancer Care page 0.508742 PDQ database 0.482266 health 0.549208 childhood cancer survivor 0.513387 people 0.5314 PDQ summary 0.514038 nicotine gum 0.499264 cancer clinical trials 0.526839 risk factors 0.570886 Public Health Service 0.486542 cancer information summaries 0.523287 comprehensive cancer information 0.523579	CLICK HERE
1555	National Cancer Institute	Html	en	Chronic Myelogenous Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.	red blood cells 0.704307 cancer treatment 0.518767 blast cells 0.52224 blast cells increases 0.484236 following PDQ summaries 0.473092 PDQ cancer information 0.548139 clinical trial search 0.530856 bone marrow disease 0.473382 white blood cells 0.672062 donor stem cell 0.54478 clinical trials 0.856546 mature blood cells 0.534844 cancer information summary 0.513437 clinical trial 0.70787 stem cell transplant 0.622548 patients 0.481704 blood cells 0.749352 chronic myelogenous leukemia 0.997869 immature cells 0.473394 treatment clinical trial 0.482118 NCI PDQ cancer 0.480305 Treatment Editorial Board 0.48584 tyrosine kinase inhibitor 0.593512 treatment 0.640788 myeloid stem cell 0.492405	stored stem cells 0.491127 immature blood cells 0.498369 blood stem cell 0.484429 tyrosine kinase 0.602514 NCI-supported cancer 0.478389 cancer cells 0.519678 lymphoid stem cell 0.493179 specific cancer cells 0.502587 tyrosine kinase inhibitors 0.484134 stem cell 0.637917 treatment clinical trials 0.506841 blood stem cells 0.543194 National Cancer Institute 0.512761 healthy white blood 0.495783 new treatment 0.554317 white blood cell 0.525778 chronic granulocytic leukemia 0.476374 bone marrow 0.760079 blastic phase 0.485946 cancer clinical trials 0.539698 cancer 0.652333 information 0.55566 Myelogenous Leukemia Treatment 0.486009 standard treatment 0.485468	CLICK HERE
1676	National Cancer Institute	Html	en	Langerhans Cell Histiocytosis Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.	LCH lesions. 0.60623 skin lch 0.608961 high-risk LCH cases 0.650922 LCH lesions 0.663265 single-system LCH 0.624334 children 0.471295 pediatric LCH 0.607323 LCH cells 0.745404 myeloid dendritic cell 0.510622 diabetes insipidus 0.672442 Langerhans cell histiocytosis 0.581215 patients 0.683188 LCH cases 0.700352 active LCH 0.597856 multisystem involvement 0.464638 multisystem LCH 0.682353 BRAF V600E mutation 0.597618 LCH 0.901252 skin-only lch 0.612216 low-risk multisystem patients 0.491439 lung LCH cases 0.608969 high-risk multisystem disease 0.475673 myeloid dendritic cells 0.467176 aggressive LCH 0.578735 high-risk patients 0.467752	multisystem low-risk LCH 0.641412 involvement 0.465609 adult patients 0.4596 adult lung LCH 0.600979 multiorgan LCH resistant 0.594436 central diabetes insipidus 0.487545 initial LCH diagnosis 0.610781 multisystem disease 0.512583 Peribiliary LCH cells 0.620201 disease 0.533739 LCH biopsy specimens 0.639356 hepatic LCH present 0.615144 pulmonary LCH cases 0.613089 LCH cells results 0.654905 LCH patients 0.65009 LCH results 0.628645 childhood LCH 0.575582 bone marrow 0.506353 diabetes insipidus patients 0.500508 diabetes insipidus onset 0.465094 diabetes insipidus development 0.465011 term LCH cells 0.651456 pulmonary lch 0.712872 low-risk multisystem disease 0.474286	CLICK HERE
2039	National Cancer Institute	Html	es	Exámenes de detección del cáncer de piel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar sistemáticamente el cáncer de piel.	skin cancer 0.943888 pediatric melanoma 0.526248 cutaneous melanoma 0.524708 incidence estimate 0.432333 pediatric melanoma mortality 0.475024 Waldmann A 0.448643 pruebas directas 0.467472 accessed october 0.431704 American Cancer Society 0.752465 largo plazo 0.427741 incidencia promedio 0.427245 Am Acad Dermatol 0.559713 Skin biopsy 0.467836 CA Cancer 0.436346 Preventive Services Task 0.49324 Melanoma mortality following 0.47412 Instituto Nacional 0.477662 diagnosing melanoma 0.465782 Melanoma Pathology Study 0.472332 PDQ Exámenes 0.446099 malignant skin tumors 0.44617 Skin biopsy utilization 0.44782 Estados Unidos 0.486058 study comparing trends 0.42068 Skin biopsy rates 0.447638	JAMA Dermatol 0.430327 US Preventive Services 0.448303 melanoma incidence among 0.478575 Nolte S 0.427295 Rogers HW 0.427126 consecuencias adversas 0.434206 Gandini S 0.430629 estudio screen 0.45426 United States 0.464438 Arch Dermatol 0.504577 Cancer Facts 0.476716 Weinstock MA 0.509901 National Cancer Institute 0.43929 Systematic skin 0.44278 population-based screening intervention 0.428982 Services Task Force 0.491749 radiación uv 0.425917 Dermatol Surg 0.429711 systematic review 0.43149 melanoma mortality 0.579785 BMC Cancer 0.438009 malignant melanoma 0.574467 nonmelanoma skin cancer 0.673873 Lott JP 0.429356	CLICK HERE
2072	National Cancer Institute	Html	es	Teléfonos celulares y el riesgo de cáncer	Hoja informativa que resume la evidencia disponible acerca del uso de los teléfonos celulares y el riesgo de cáncer.	CERENAT case-control study 0.411745 multicenter case-control study 0.411414 epidemiological study results 0.41093 rayos x 0.411877 brain glucose metabolism 0.429587 case-control study 0.426606 único efecto 0.412309 tumores benignos 0.415961 GSM mobile 0.415087 incidence trends 0.411018 Ningún estudio 0.417181 y el riesgo 0.411067 estudio cerecat 0.417392 nationwide cohort study 0.411491 estudio cefalo 0.417908 NCI evaluó la incidencia 0.412387 Schüz J 0.443349 posibles efectos 0.437506 Estudio Danés 0.41724 Estados Unidos 0.572662 teléfonos análogos 0.439875 teléfonos celulares. Todavía 0.442397 PubMed Abstract 0.994162 ambicioso estudio 0.416033 menor riesgo 0.411527	Danish cohort study 0.411708 mobile phone 0.603266 International Agency 0.410998 cerebral blood flow 0.418576 Johansen C 0.418262 International Journal 0.433338 malignant brain tumours 0.413167 estudio conjunto 0.41602 cohort study 0.416338 Deltour I 0.41865 British Medical Journal 0.421146 brain neoplasms 0.419629 brain tumor risk 0.416486 brain tumours 0.444382 teléfonos celulares y tumores 0.450845 participantes controles 0.41861 international case-control study 0.411613 sistema nervioso central 0.469236 brain tumor 0.443081 cerebro quizás 0.419107 Cancer Institute 0.432735 teléfonos celulares causa 0.474528 pequeños estudios 0.411116 teléfonos celulares análogos 0.479549	CLICK HERE
3459	National Cancer Institute	Html	es	Coenzima Q10 (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la conzima Q10 como tratamiento para las personas con cáncer.	Centro Nacional 0.333125 Vitamina Q10 0.341732 New Hampshire Avenue 0.323053 Drug Administration 0.314317 leucemia linfoblástica aguda 0.341078 NCI Best Case 0.342133 vía oral 0.324149 mejores pruebas 0.318969 datos bibliográficos pubmed 0.324983 siguientes preguntas 0.314202 mayores cantidades 0.322901 Premio Nobel 0.323381 siguientes riesgos 0.318032 máximo nivel 0.322444 seguro médico 0.313926 Instituto Nacional 0.428917 vitamina e 0.322593 conzima q10 0.331342 Salud Complementaria 0.35167	Visuals Online 0.317138 complementarias revisa 0.324022 daños causados​por 0.322061 Physician Data Query 0.399292 coenzima q10 0.631002 Estados Unidos 0.532938 cáncer doxorrubicina 0.420236 antraciclina doxorrubicina 0.326213 libre uso 0.31803 página manejo 0.315983 ¿El tratamiento 0.336183 ¿Los beneficios 0.314951 CoQ10 ayuda 0.788819 cuerpo elabora 0.394571 coenzima ayuda 0.33485 Series Program 0.314402 medicina complementaria 0.970585 siguientes deficiencias 0.324091	CLICK HERE
3521	National Cancer Institute	Html	en	NCI-MATCH Trial (Molecular Analysis for Therapy Choice)	Information about the NCI-MATCH precision medicine trial, in which patients with advanced solid tumors and lymphomas are assigned to treatment arms based on the molecular profiles of their disease.	NCI-MATCH trial 0.544063 rare cancer 0.541344 COMET study 0.578429 genetic makeup 0.540259 trial 0.805751 clinical trial tracking 0.631222 usual genomic testing 0.608947 National Clinical Trials 0.604691 MATCH protocol summary 0.637152 treatment arms 0.751732 clinical trials 0.747821 newly enrolling patients 0.642185 MATCH trial 0.634351 health care professionals 0.58508 cancer care 0.539135 patients 0.983397 cancer patients 0.598511 tumor gene testing 0.590848 ECOG-ACRIN Cancer Research 0.612355 non-small cell lung 0.606702 objective response rate 0.771639 medicine cancer treatment 0.706859 genomic sequencing 0.623041 treatment arms address 0.659842	gene sequencing lab 0.599434 specific genetic change 0.644953 laboratory method 0.524995 Cancer Trials Support 0.616424 potential MATCH participants 0.636971 cancer cells 0.549314 common genetic changes 0.635293 Cancer Information Service 0.610926 clinical trial. 0.538943 genetic change 0.741928 adult trial groups 0.623508 health insurance company 0.59001 enrolled patients 0.575046 progression-free survival 0.609538 specific genetic changes 0.64881 NCI Community Oncology 0.61311 particular genetic change 0.630183 new tumor biopsy 0.621774 genetic changes 0.811113 MATCH treatment arm 0.848463 Caris Life Sciences 0.607515 NRG Oncology Group 0.586136 advanced solid tumors 0.669501 new clinical sites 0.600949	CLICK HERE
3581	National Cancer Institute	Html	en	Cancer Screening and Early Detection Research	Information about cancer screening and early detection research, including a summary of NCI programs dedicated to advancing screening and early detection.	new screening test 0.540118 cancer deaths 0.410053 NCI family studies 0.383067 lung cancer 0.420741 Breast Cancer Surveillance 0.38723 regular screening 0.445893 colorectal cancer screening 0.603772 early detection 0.939503 certain cancers 0.363738 nonhereditary cancers 0.350447 cancer diagnosis 0.409297 Early Detection Research 0.39067 Colorectal Cancer Outreach 0.419418 invasive diagnostic tests 0.349791 cervical cancer 0.470854 Reduce Cancer Health 0.403575 follow-up screening 0.454414 population groups 0.405687 cancers 0.545666 effective screening tests 0.700094 cancer screening 0.952427 esophageal cancer 0.349174 cancer prevention 0.403966 cancer screening practices 0.592194 United States 0.470337	screening tests 0.828502 early detection tests 0.394525 Cancer Treatment 0.361701 cancer cells 0.354406 new screening tests 0.532154 successful screening approach 0.50247 annual screening 0.507755 screening clinical trials 0.513432 National Lung Screening 0.514111 breast cancer screening 0.628104 potentially lethal cancers 0.414445 advanced cancer 0.354994 Research Optimizing Screening 0.517143 screen-detected cancers 0.368122 cancer screening tests 0.606127 CT-based screening 0.448353 hereditary cancers 0.34998 lung cancer risk 0.409654 false-positive screening tests 0.535547 Screening Initiative 0.447841 cancer mortality 0.418544 screening methods 0.487692 Cancer Screening Trial 0.590657 life-threatening cancers 0.360993	CLICK HERE
15671	National Cancer Institute	Html	en	National Cancer Institute Overview and Mission	Learn about the National Cancer Institute and what we do, our impact, and our future plans.	NCI Budget Fact 0.497121 federally funded research 0.465442 research education 0.373076 cancer deaths 0.368559 research efforts 0.378749 clinical trial sites 0.42553 improved cancer treatments 0.481082 new cancer cases 0.455562 private-sector life sciences 0.407381 research career development 0.478109 clinical trials 0.413733 publicly available cancer 0.474225 National Institutes 0.330098 cancer patients 0.381628 research laboratories 0.378804 comprehensive training programs 0.420146 NCI 0.551669 clinical research 0.391338 cancer survivors 0.364801 training opportunities 0.416201 intramural training programs 0.437578 National Cancer Program 0.503712 career development opportunities 0.414542 Funds training 0.333548 advanced technology development 0.398899	Maintains long-term storage 0.390918 cancer prevention 0.393108 United States 0.478805 training grants 0.329153 cancer research 0.942525 private philanthropic organizations 0.403666 scientific knowledge 0.423431 cancer research disciplines 0.531444 various research programs 0.452562 National Cancer Institute 0.528313 NCI laboratories 0.431835 cancer researchers 0.38535 research institutions 0.37224 Supports intramural research 0.523044 innovative laboratory research 0.451762 Frederick National Laboratory 0.407026 cancer detection 0.370327 NCI’s expenditures 0.416543 career development 0.479695 cancer care delivery 0.459112 biomedical research 0.373736 cancer research enterprise 0.566317 NCI’s laboratories 0.427372 NCI-Designated Cancer Centers 0.493446	CLICK HERE
16374	National Cancer Institute	Html	en	Cancer Moonshot℠ – Funding Opportunities	NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to accelerate cancer research.	Cancer Drug Resistance 0.295868 Science Network Cancer 0.308038 Human Tumor Atlases 0.404045 Immunotherapy Translational Science 0.984441 Science Accelerating Colorectal 0.287912 Fusion Oncoproteins 0.307628 Cancer Immunoprevention Research 0.286973 Cancer Immunotherapy Translational 0.970237 Network Pediatric Immunotherapy 0.362271 Pediatric Immunotherapy Discovery 0.349074 Tumor Atlases Human 0.296142 Implementation Science Improving 0.29186 Translational Science Network 0.875874 Management Research Research 0.283205 New Enabling Technologies 0.348633 Network Metabolic Reprogramming 0.28898 Immuno-Oncology Translation Network 0.34437 Promote Research Collaborations 0.285621 Science Improving Smoking 0.284218 Colorectal Cancer Screening 0.294277 Research Projects 0.27874 Cancer Data Ecosystem 0.284367 Science Network Metabolic 0.302007 Cancer Moonshot 0.286234 Network Canine Immunotherapy 0.334919	Implementation Science Accelerating 0.293234 PHS2018-1/ Topic 0.305631 Research Centers 0.280481 Network Immuno-Oncology Translation 0.344385 Cancer Immunotherapy Research 0.375931 Symptom Management Research 0.365508 Childhood Cancers 0.296073 Science Network Research 0.294604 Early Detection 0.350699 Accelerating Colorectal Cancer 0.296449 National Cancer Data 0.285248 Science Network Coordinating 0.277495 Network Cancer Immunologic 0.279507 Canine Immunotherapy Trials 0.339278 Network Cancer Immune 0.278836 Translational Studies 0.295595 Human Tumor Atlas 0.288789 Translational Research 0.303812 Cancer Moonshot-related activities 0.277278 Immunotherapy Data Resource 0.338479 Atlases Human Tumor 0.296132 Science Network Pediatric 0.294096 Science Network Immuno-Oncology 0.350197 Implementation Science 0.370631	CLICK HERE